Aprameya Engineering
APRAMEYA NSE
Aprameya Engineering
HealthcareNSE: APRAMEYA Medical Equipment
Key Fundamentals
SMEMedical EquipmentHealthcareMarket Cap
₹232 Cr
Volatility
Moderate
P/E Ratio
44.9
EBITDA
₹11.00 Cr
Return on Equity
7.37%
Debt to Equity
0.1
Book Value
₹36.45
52W High
₹360
52W Low
₹102.1
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Company has reduced debt.
Weaknesses
4- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 368 days.
- Company's cost of borrowing seems high
- Working capital days have increased from 232 days to 377 days
Growth Rate
Revenue Growth
-59.21% lower than
3Y
Net Income Growth
-68.32% lower than
3Y
Cash Flow Change
394% higher than
3Y
ROE
-70.61%
ROCE
-56.86%
EBITDA Margin (Avg.)
8.07%
Quarterly Results
| Particulars | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 9.27 | 126 | 42.14 | 12.61 |
| Expenses | 10.65 | 101 | 31.12 | 13.21 |
| Operating Profit | -1.38 | 25.78 | 11.02 | -0.6 |
| OPM % | -14.89% | 20.39% | 26.15% | -4.76% |
| Other Income | 0.28 | 0.31 | 0.19 | 0.29 |
| Interest | 1.15 | 2.03 | 2.03 | 1.61 |
| Depreciation | 0.05 | 0.05 | 0.05 | 0.05 |
| PBT | -2.3 | 24.01 | 9.13 | -1.97 |
| Tax % | -24.78% | 25.7% | 25.96% | -12.18% |
| Net Profit | -1.73 | 17.84 | 6.76 | -1.72 |
| EPS in Rs | -0.91 | 9.37 | 3.55 | -0.9 |
Profit & Loss
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 12.23 | 25.93 | 35 | 78.12 | 65.16 | 136 | 54.75 |
| Expenses | 10.64 | 23.52 | 24.95 | 68.67 | 58.81 | 111 | 44.34 |
| Operating Profit | 1.59 | 2.41 | 10.05 | 9.45 | 6.35 | 24.4 | 10.41 |
| OPM % | 13% | 9.29% | 28.71% | 12.1% | 9.75% | 17.98% | 19.01% |
| Other Income | 0.09 | 0.08 | 0.04 | 0.21 | 0.46 | 0.59 | 0.49 |
| Interest | 0.9 | 0.87 | 0.14 | 2.08 | 2.11 | 3.18 | 3.64 |
| Depreciation | 0.07 | 0.09 | 0.02 | 0.08 | 0.09 | 0.09 | 0.09 |
| PBT | 0.71 | 1.53 | 9.93 | 7.5 | 4.61 | 21.72 | 7.17 |
| Tax % | 8.45% | 43.79% | 24.87% | 27.33% | 24.3% | 25.78% | 29.71% |
| Net Profit | 0.65 | 0.86 | 7.46 | 5.45 | 3.49 | 16.12 | 5.04 |
| EPS in Rs | — | — | 10.66 | 3.89 | 2.49 | 8.47 | 2.65 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 3.74 | 4.34 | 7 | 14 | 14 | 19.04 | 19.04 |
| Reserves | 0 | 0 | 7.45 | 5.93 | 9.4 | 45.22 | 50.3 |
| Borrowings | 4.03 | 1.48 | 13.69 | 28.74 | 42.05 | 30.34 | 7.12 |
| Other Liabilities | 6.21 | 5.09 | 20.49 | 13.21 | 10.19 | 49.36 | 5.4 |
| Total Liabilities | 13.98 | 10.91 | 48.63 | 61.88 | 75.64 | 144 | 81.86 |
| Fixed Assets | 0.69 | 0.63 | 1.54 | 1.49 | 1.43 | 1.38 | 1.39 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0.35 |
| Other Assets | 13.29 | 10.28 | 47.09 | 60.39 | 74.21 | 143 | 80.12 |
| Total Assets | 13.98 | 10.91 | 48.63 | 61.88 | 75.64 | 144 | 81.86 |
Cash Flow
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | 0.06 | 3.58 | 10.41 | -13.49 | -9.97 | -10.64 | 31.48 |
| Investing | -0.57 | 0.03 | -0.24 | -1.83 | -1 | -0.41 | -4.01 |
| Financing | 0.54 | -3.67 | -7.69 | 13.04 | 11.11 | 10.89 | -27.65 |
| Net Cash Flow | 0.04 | -0.06 | 2.48 | -2.28 | 0.14 | -0.16 | -0.18 |
| Free Cash Flow | -0.31 | 3.55 | 10.38 | -13.52 | -10.58 | -10.89 | 31.31 |
| CFO/OP | 22 | 173 | 149 | -115 | -133 | -28 | 333 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 182 | 57.99 | 278 | 195 | 325 | 320 | 368 |
| Inventory Days | 245 | 122 | 455 | 376 | 73.78 | — | 81.04 |
| Days Payable | 269 | 147 | 1,100 | 415 | 146 | — | 95.38 |
| Cash Conversion Cycle | 159 | 33.13 | -367 | 157 | 253 | 320 | 354 |
| Working Capital Days | 39.69 | 36.32 | 200 | 116 | 153 | 166 | 377 |
| ROCE % | — | 35.32% | 59.31% | 24.94% | 11.78% | 31.12% | 12.64% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Aprameya Engineering insights
61 extracted metrics + investor summaries across FY15–FY26.
Documents
1
Shareholders meeting
3 Aug - AGM held on 1 Aug 2026; all resolutions, including FY26 financial adoption, passed. 3 Aug - AGM held on 1 Aug 2026; all resolutions, including FY26 financial adoption, passed.
2
Shareholders meeting
1 Aug - Aprameya Engineering held its 5th AGM on 1 August 2026; voting results to follow. 1 Aug - Aprameya Engineering held its 5th AGM on 1 August 2026; voting results to follow.
3
Disclosure under SEBI Takeover Regulations
23 Jul - Promoters disclosed no additional share encumbrance for FY2025. 23 Jul - Promoters disclosed no additional share encumbrance for FY2025.
4
Disclosure under SEBI Takeover Regulations
23 Jul - Promoters disclosed no new encumbrance on shares for year ended 31 March 2025. 23 Jul - Promoters disclosed no new encumbrance on shares for year ended 31 March 2025.
5
Structural Digital Database
21 July 2026 - Aprameya Engineering submits FY26 SDD compliance certificate; no non-compliance reported. 21 July 2026 - Aprameya Engineering submits FY26 SDD compliance certificate; no non-compliance reported.
Frequently Asked Questions about Aprameya Engineering
What does Aprameya Engineering Ltd do?
Incorporated in September 2003, Aprameya Engineering Limited specializes in installing and maintaining Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatres, and prefabricated structure wards in hospitals and medical care cente...
Where is Aprameya Engineering Ltd (APRAMEYA) listed?
Aprameya Engineering Ltd trades as APRAMEYA on the NSE.
Which sector does Aprameya Engineering Ltd belong to?
Aprameya Engineering Ltd is classified under the Healthcare sector, in the Medical Equipment industry.
What is the market capitalisation of Aprameya Engineering Ltd?
Aprameya Engineering Ltd has a market capitalisation of ₹232.29 Cr, which places it in the Small Cap band.
What is the PE ratio of Aprameya Engineering Ltd?
Aprameya Engineering Ltd trades at a PE ratio of 44.90, against a book value of ₹36.45 per share.
What is the 52-week high and low of Aprameya Engineering Ltd?
Over the last 52 weeks Aprameya Engineering Ltd has traded between ₹102.1 and ₹360.
What is the Return on Equity (ROE) of Aprameya Engineering Ltd?
Aprameya Engineering Ltd reported a return on equity of 7.37%. Its debt-to-equity ratio is 0.10.
Company Information
Incorporated in September 2003, Aprameya Engineering Limited specializes in installing and maintaining Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatres, and prefabricated structure wards in hospitals and medical care centers.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/APRAMEYA.md for Aprameya Engineering Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.